Acrivon Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAcrivon Therapeutics

Acrivon Therapeutics(ACRV)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

stomach neoplasms

,

brain neoplasms

,

pancreatic neoplasms

,

,

,

cholangiocarcinoma

,

hepatocellular carcinoma

,

liver neoplasms

,

,

triple negative breast neoplasms

,

urinary bladder neoplasms

,

urinary bladder diseases

,

renal cell carcinoma

,

neoplasm metastasis

,

transitional cell carcinoma

,

hodgkin disease

,

meningeal neoplasms

,

non-small-cell lung carcinoma

,

colorectal neoplasms

,

,

,

rectal neoplasms

,

pancreatic ductal carcinoma

,

large b-cell lymphoma diffuse

,

colonic neoplasms

,

,

,

b-cell lymphoma

,

gastrointestinal neoplasms

,

digestive system neoplasms

,

rectal diseases

,

gastrointestinal diseases

,

intestinal neoplasms

,

digestive system diseases

,

colonic diseases

,

intestinal diseases

,

non-hodgkin lymphoma

,

,

drug-related side effects and adverse reactions

,

,

male breast neoplasms

,

hand-foot syndrome

,

acquired immunodeficiency syndrome

,

breast neoplasms

,

,

,

,

endometrial neoplasms

,

endometrioid carcinoma

,

squamous cell carcinoma of head and neck

Histone-arginine methyltransferase carm1

prostatic hyperplasia

,

psychological sexual dysfunctions

,

anxiety disorders

,

generalized anxiety disorder

,

pulmonary hypertension

,

,

erectile dysfunction

,

spinal cord injuries

,

type 2 diabetes mellitus

,

,

non-small-cell lung carcinoma

,

,

,

neoplasm metastasis

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use